OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
4.660
-0.370 (-7.36%)
At close: Nov 20, 2026, 4:00 PM EST
4.640
-0.020 (-0.43%)
After-hours: Nov 20, 2026, 7:43 PM EST
OmniAb Market Cap
OmniAb has a market cap or net worth of $679.71 million as of November 20, 2026. It is the 11,744th most valuable company in the world and the 2,416th biggest in the United States. Its market cap has increased by 186.16% in one year.
Market Cap
679.71M
Enterprise Value
633.64M
1-Year Change
186.16%
Global Rank
Country Rank
#2,416 United States
Category
ChartMarket Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $679.71M, a decrease of -31.54%. That is a compound annual growth rate of -8.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 679.71M | 155.23% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
| Oct 25, 2022 | 992.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rigel Pharmaceuticals | 775.61M |
| Ardelyx | 769.20M |
| Monte Rosa Therapeutics | 761.36M |
| Obsidian Therapeutics | 750.54M |
| Lexicon Pharmaceuticals | 743.54M |
| Aura Biosciences | 726.44M |
| Solid Biosciences | 718.77M |
| Apnimed | 717.92M |